Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
about
Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factorGenetic interstitial lung diseaseMultiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.The molecular basis of pulmonary alveolar proteinosisPatient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.Genetic Basis of Children's Interstitial Lung Disease.MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategies.Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment?The colony-stimulating factors and cancer.Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1.An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.Accessing the human repertoire for broadly neutralizing HIV antibodies.Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis.Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges.Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013.Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis.Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis.Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage.Cytopathological examination of bronchoalveolar lavage fluid in diagnosis of pulmonary alveolar proteinosis.Alveolar proteinosis associated with aluminium dust inhalation.
P2860
Q24323199-5ED68A16-7B93-41DB-9F27-96D617FE04C9Q24626239-9C29BCA0-FE1A-42F8-9101-A1D56E03751BQ28384372-BACE0D11-485F-4AC6-B6E8-480C5AE5EF57Q33835843-A1781995-7293-4C6F-A84B-422C51E8ABBFQ33988125-C4B1DEB0-046E-4003-88F1-7046C065B6BFQ34402453-BB2F0188-CF41-43B7-A3CD-253A15F78577Q35513452-8D8396DE-4944-4B4C-AD85-07F38797273DQ35605418-C35C5AB5-EDB5-4593-B2B2-66F98AF7F014Q35879038-C45538BE-F1B4-4FCF-8DA1-CAB62C8C1D2DQ35879043-B8BF73D2-5FFE-4C00-81B5-C00CC3C943E0Q35936937-0ABD61DE-E33B-4220-B115-2840B53003B8Q36203148-5B473254-9BBA-42A3-A27C-AE9B9ECF0223Q36204781-59AA71C9-FA81-4A83-8B99-9EFA9CC737FDQ36979986-558F015E-0F17-4F73-A2CC-9046B3E16ACAQ37418292-F8DD5FFB-2FBA-4ACD-B295-D1B1B334445DQ37427088-6F3F3BA2-3400-4A28-A14A-980201F20E84Q37694976-7FD0507B-F8D1-4882-A587-0FCD9F41C225Q37771906-620D97AF-EE66-42D2-8996-A5E9D3DC42D5Q38041659-2605118D-B3DA-4E26-A308-723A5BCD36A0Q38049370-8E20F5F4-3689-4431-992D-9028F2E7EA16Q42176757-0E2239EB-76ED-42E7-AF89-FC930E9A0F49Q43058950-83BD799E-ABE3-4ED0-9759-FA0523B1A31FQ44477055-ED284BA7-7B54-41E8-8B41-D306BF9D2EF8Q44535674-8CA89EDF-C4F5-4EE7-A244-64A02637AAF6Q45091543-90C5181E-FB28-4793-8243-18435B21E5DDQ47691658-327D104D-05B2-4DB8-B52E-E140F609974FQ47908790-D8348862-75C7-43DE-A371-3F231E93636BQ49768289-3B2E8AC4-DCA4-4BFD-A273-15DA9D06EB60Q51531172-702F2E04-B647-4F13-BB1D-A96793011DE0
P2860
Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@en
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@nl
type
label
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@en
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@nl
prefLabel
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@en
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@nl
P2093
P2860
P356
P1476
Autoantibodies against granulo ...... ulmonary alveolar proteinosis.
@en
P2093
Anagha Malur
Debra Russell
Mani S Kavuru
Mary Jane Thomassen
Sujata Burgess
Tracey L Bonfield
P2860
P304
P356
10.1165/RCMB.2002-0023OC
P577
2002-10-01T00:00:00Z